Xiaoqin Run
- Physiology top 10%
- Molecular Biology
- Cellular and Molecular Neuroscience top 10%
- Developmental Neuroscience top 5%
- Neurology top 10%
- Topics
- Alzheimer's disease research and treatments (7 papers)Neuroscience and Neuropharmacology Research (5 papers)Anesthesia and Neurotoxicity Research (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaoqin Run
16 papers receiving 715 citations
Peers
Comparison fields: 5 of 70
- Physiology 338
- Molecular Biology 292
- Cellular and Molecular Neuroscience 155
- Developmental Neuroscience 128
- Neurology 114
Countries citing papers authored by Xiaoqin Run
This map shows the geographic impact of Xiaoqin Run's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoqin Run with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoqin Run more than expected).
Fields of papers citing papers by Xiaoqin Run
This network shows the impact of papers produced by Xiaoqin Run. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoqin Run. The network helps show where Xiaoqin Run may publish in the future.
Co-authorship network of co-authors of Xiaoqin Run
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoqin Run. A scholar is included among the top collaborators of Xiaoqin Run based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoqin Run. Xiaoqin Run is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 1 | |
| 3 | 25 | |
| 4 | 102 | |
| 5 | 43 | |
| 6 | 56 | |
| 7 | 18 | |
| 8 | 6 | |
| 9 | 89 | |
| 10 | 10 | |
| 11 | 78 | |
| 12 | 5 | |
| 13 | 1,5-dicaffeoylquinic acid protects primary neurons from amyloid β 1-42-induced apoptosis via PI3K/Akt signaling pathway. | 20 |
| 14 | 18 | |
| 15 | 145 | |
| 16 | 97 |
About Xiaoqin Run
Xiaoqin Run is a scholar working on Developmental Neuroscience, Critical Care and Intensive Care Medicine and Cellular and Molecular Neuroscience, having authored 16 papers that have together received 725 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and Anesthesia and Neurotoxicity Research (4 papers). The work is most often cited by research in Developmental Neuroscience (128 citations), Critical Care and Intensive Care Medicine (109 citations) and Neurology (114 citations). Xiaoqin Run has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhihou Liang, Cheng‐Xin Gong, Khalid Iqbal, Fei Liu, Inge Grundke‐Iqbal, Yang Yu, Chun‐Ling Dai, Yi Li, Yanxing Chen and Ying Liu. Their work appears in journals such as PLoS ONE, Journal of Neurochemistry and Experimental Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.